Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Meeting Abstract | 2023 ASCO Genitourinary Cancers Symposium

<< Previous

Bullboard Posts

Next >>

Comment by Rumpl3StiltSkinon May 07, 2023 9:30am

206 Views

Post# 35435177

RE:RE:RE:Meeting Abstract | 2023 ASCO Genitourinary Cancers Symposium

If we crunch the latest numbers similar to Nov., and eliinate the Phase 1 data, we end up with a 450 day CR of 33% CR + IR is higher % obviously. I think since the FDA is after CR at any time %s then those numbers also look very good.

<< Previous

Bullboard Posts

Next >>

5 steps to mastering risk management in the stock market